M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, and Australia. The company operates in two segments, Beauty and Trade. It offers aesthetic medical treatments under the M1 Med Beauty brand name across specialist centres; offers surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin, as well as manages a private clinic for plastic and aesthetic surgery under the M1 Schlossklinik brand name. The company also distributes pharmaceutical and medical devices in the therapeutic areas comprising oncology, HIV/AIDS, neurology, rheumatology, and other chronic diseases. M1 Kliniken AG was founded in 2007 and is headquartered in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.
Stock data | 2024 | Change |
---|---|---|
Price | $19.62 | N/A |
Market Cap | $359.30M | N/A |
Shares Outstanding | 18.32M | N/A |
Employees | 366.00 | N/A |